bafetinib

DRUG3 trials

Sponsors

CytRx, City of Hope Medical Center

Conditions

Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic OligoastrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaAdult Mixed Glioma

Phase 1

Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases

CompletedNCT01234740

City of Hope Medical CenterAdult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligoastrocytoma +7

Start: 2010-12-31End: 2013-03-31Updated: 2018-04-17

Phase 2

Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

CompletedNCT01144260

CytRxB-Cell Chronic Lymphocytic Leukemia

Start: 2010-06-30End: 2013-04-30Updated: 2013-05-15

Study of Bafetinib (INNO-406) as Treatment for Patients With Hormone-Refractory Prostate Cancer

CompletedNCT01215799

CytRxHormone Refractory Prostate Cancer

Start: 2010-08-31End: 2011-12-31Updated: 2011-12-15